• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植合并膀胱输尿管反流患者输尿管口下注射成功的预测因素。

Predictive factors for the success of subureteric injection in renal transplant patients with vesicoureteral reflux.

作者信息

Varol Alkım Tolga, Caylan Ahmet Ender, Uçar Murat

机构信息

Department of Urology, Akdeniz University School of Medicine, Antalya, Turkey.

出版信息

BMC Urol. 2025 Apr 16;25(1):92. doi: 10.1186/s12894-025-01779-7.

DOI:10.1186/s12894-025-01779-7
PMID:40241102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12004796/
Abstract

BACKGROUND

Predicting the success of endoscopic treatment of VUR in transplant patients may not only protect both the physician and the patient from unnecessary investigations and treatment but may also prolong the life of the graft by preventing possible loss of time.

METHODS

This retrospective study included 116 patients with vesicoureteral reflux following kidney transplantation between 2014-2022. Demographic data, preoperative and intraoperative clinical aspects, and postoperative 6-month success rates were evaluated.

RESULTS

The success rate of the injection treatment in the 6 month was 41.4%. As the patient age decreased, the success rate of the injection decreased (p = 0.025). While no significant relationship was observed between the preoperative reflux grade, injected volume of the bulking agent, and success (p = 0.109 and 0.222, respectively), a significant decrease in success was observed with an increase in UDR (p < 0.001) in group comparison. Regression analyses demonstrated that pre-injection visual assessment and post-injection orifice mound view influenced the success rate (p < 0.001 and p < 0.001, respectively).

CONCLUSIONS

Intraoperative visual assessment of the orifice is a reliable indicator for predicting the success of subureteric injection. It not only provides patients with trustworthy postoperative information but also saves clinicians time by anticipating the next surgical stage, ultimately contributing to the prolongation of graft life.

摘要

背景

预测移植患者膀胱输尿管反流内镜治疗的成功率,不仅可以使医生和患者避免不必要的检查和治疗,还可以通过防止可能的时间浪费来延长移植物的寿命。

方法

这项回顾性研究纳入了2014年至2022年间116例肾移植后发生膀胱输尿管反流的患者。评估了人口统计学数据、术前和术中的临床情况以及术后6个月的成功率。

结果

注射治疗6个月时的成功率为41.4%。随着患者年龄的降低,注射成功率也降低(p = 0.025)。虽然术前反流分级、填充剂注射量与成功率之间未观察到显著相关性(p分别为0.109和0.222),但在组间比较中,随着UDR的增加,成功率显著降低(p < 0.001)。回归分析表明,注射前视觉评估和注射后孔口隆起视图影响成功率(p分别< 0.001和p < 0.001)。

结论

术中对孔口的视觉评估是预测输尿管下注射成功率的可靠指标。它不仅为患者提供了可信的术后信息,还通过预测下一手术阶段节省了临床医生的时间,最终有助于延长移植物寿命。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac8/12004796/798a0e7d2260/12894_2025_1779_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac8/12004796/692f06edd979/12894_2025_1779_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac8/12004796/f3f6f9a3fb0e/12894_2025_1779_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac8/12004796/798a0e7d2260/12894_2025_1779_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac8/12004796/692f06edd979/12894_2025_1779_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac8/12004796/f3f6f9a3fb0e/12894_2025_1779_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac8/12004796/798a0e7d2260/12894_2025_1779_Fig3_HTML.jpg

相似文献

1
Predictive factors for the success of subureteric injection in renal transplant patients with vesicoureteral reflux.肾移植合并膀胱输尿管反流患者输尿管口下注射成功的预测因素。
BMC Urol. 2025 Apr 16;25(1):92. doi: 10.1186/s12894-025-01779-7.
2
Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?影响膀胱输尿管反流内镜治疗成功的因素及两种基于葡聚糖omer的填充剂的比较:填充物质重要吗?
J Pediatr Urol. 2015 Apr;11(2):90.e1-5. doi: 10.1016/j.jpurol.2014.12.009. Epub 2015 Mar 2.
3
A comparison between dextranomer/ hyaluronic acid and polyacrylate polyalcohol copolymer as bulking agents for treating primary vesicoureteral reflux.右旋糖酐/透明质酸与聚丙烯酸多元醇共聚物作为治疗原发性膀胱输尿管反流填充剂的比较。
Urol J. 2019 May 5;16(2):174-179. doi: 10.22037/uj.v0i0.4156.
4
High-grade vesicoureteral reflux in infants: Our experience with endoscopic subureteric injections.婴儿高级别膀胱输尿管反流:我们经内镜下输尿管内注射治疗的经验。
Urologia. 2022 Feb;89(1):120-125. doi: 10.1177/0391560320966187. Epub 2020 Oct 16.
5
Ultrasound-based predictive indicators for treatment outcomes in pediatric vesicoureteral reflux.基于超声的预测指标在小儿膀胱输尿管反流治疗中的应用。
Surg Today. 2024 Oct;54(10):1265-1271. doi: 10.1007/s00595-024-02833-x. Epub 2024 Apr 16.
6
Antireflux endoscopic injection therapy in post-pubertal patients via techniques adopted for the dilated ureteral orifice: a retrospective single-center study.经输尿管口扩张技术行抗反流内镜下注射治疗青春期后患者:回顾性单中心研究。
BMC Urol. 2021 Apr 24;21(1):70. doi: 10.1186/s12894-021-00842-3.
7
Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children.两种填充剂用于儿童IV级和V级膀胱输尿管反流的内镜治疗:葡聚糖硫酸钠-透明质酸共聚物与聚丙烯酸多元醇共聚物的比较
J Pediatr Surg. 2016 Oct;51(10):1711-5. doi: 10.1016/j.jpedsurg.2016.03.013. Epub 2016 Apr 9.
8
Comparing treatment modalities for transplant kidney vesicoureteral reflux in the pediatric population.比较小儿肾移植后膀胱输尿管反流的治疗方式。
J Pediatr Urol. 2018 Dec;14(6):554.e1-554.e6. doi: 10.1016/j.jpurol.2018.07.006. Epub 2018 Jul 24.
9
Unilateral open extravesical ureteral reimplanation with contralateral dextronomer/hyaluronic acid injection performed as an outpatient therapy.单侧开放性经膀胱外输尿管再植术联合对侧右旋糖酐/透明质酸注射,作为门诊治疗。
J Pediatr Urol. 2018 Dec;14(6):566.e1-566.e5. doi: 10.1016/j.jpurol.2018.07.014. Epub 2018 Jul 25.
10
Endoscopic vesicoureteral reflux correction in transplanted kidneys: does injection technique matter?内镜下肾盂输尿管反流矫正术在移植肾中的应用:注射技术重要吗?
J Endourol. 2010 Oct;24(10):1661-4. doi: 10.1089/end.2010.0219.

本文引用的文献

1
Subureteric injection for the treatment of vesicoureteral reflux in transplant kidneys.输尿管下注射治疗移植肾膀胱输尿管反流
Can Urol Assoc J. 2025 Mar;19(3):E92-E97. doi: 10.5489/cuaj.8787.
2
The Effectiveness of the Surgical Correction of Vesicoureteral Reflux on Febrile Urinary Tract Infections after a Kidney Transplant: A Single-Center Retrospective Study.肾移植术后膀胱输尿管反流手术矫正对发热性尿路感染的疗效:一项单中心回顾性研究
J Clin Med. 2024 Sep 6;13(17):5295. doi: 10.3390/jcm13175295.
3
Does the distal ureteral diameter ratio (UDR) matter in the surgical management of vesicoureteral reflux in children?
在儿童膀胱输尿管反流的手术治疗中,远端输尿管直径比(UDR)是否重要?
Pediatr Surg Int. 2023 Aug 17;39(1):249. doi: 10.1007/s00383-023-05535-6.
4
Four-Point Injection Technique of Polyacrylate/Polyalcohol Copolymer in Vesicoureteral Reflux After KidneyTransplant.聚丙烯酸酯/聚醇共聚物四点注射技术治疗肾移植术后膀胱输尿管反流。
Exp Clin Transplant. 2023 May;21(5):434-440. doi: 10.6002/ect.2022.0303. Epub 2023 Apr 19.
5
Endoscopic treatment of vesicoureteral reflux after kidney transplantation: outcomes and predictive factors of clinical and radiological success.肾移植术后膀胱输尿管反流的内镜治疗:临床及影像学成功的结果与预测因素
Int Urol Nephrol. 2022 May;54(5):1023-1029. doi: 10.1007/s11255-022-03152-1. Epub 2022 Feb 21.
6
Allograft Vesicoureteral Reflux after Kidney Transplantation.肾移植后同种异体输尿管反流。
Medicina (Kaunas). 2022 Jan 5;58(1):81. doi: 10.3390/medicina58010081.
7
Long-term results of endoscopic treatment in vesicoureteral reflux after kidney transplantation.肾移植后排尿性输尿管反流的内镜治疗的长期结果。
World J Urol. 2022 Mar;40(3):815-821. doi: 10.1007/s00345-021-03902-3. Epub 2022 Jan 14.
8
Ureteral reimplantation after deflux failure for vesicoureteral reflux in renal transplant.移植肾术后反流失败行输尿管再植术治疗膀胱输尿管反流。
World J Urol. 2022 Jan;40(1):271-276. doi: 10.1007/s00345-021-03814-2. Epub 2021 Aug 20.
9
Treatment of Vesicoureteral Reflux Detected After Renal Transplant in Pediatric Patients: A Single-Center Experience.小儿肾移植后检测到的膀胱输尿管反流的治疗:单中心经验
Exp Clin Transplant. 2021 Jun;19(6):545-552. doi: 10.6002/ect.2020.0367. Epub 2021 May 6.
10
Minimal-invasive management of urological complications after kidney transplantation.肾移植术后泌尿系统并发症的微创处理。
Int Urol Nephrol. 2021 Jul;53(7):1267-1277. doi: 10.1007/s11255-021-02825-7. Epub 2021 Mar 2.